Agilent Technologies Hires Samraat “Sam” Raha to Head Strategy and Corporate Development

Former Agilent Commercial VP Brings Deep Industry and Marketing Experience to New Role SANTA CLARA, Calif., March 20, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Samraat “Sam” Raha has been named senior vice president of strategy and corporate development, reporting to Agilent President and CEO Mike McMullen. Raha will serve as strategic lead... Read more

Water Quality Testing Advances Ten Times the Current Standards with new Promega AppliTek Collaboration

Madison, WI USA. (March 16, 2017) (March 16, 2017) Rapid and reliable on-line measurement of water quality with sensitivity more than ten times current standards is now available to the water industry. Promega Corporation and AppliTek (Belgium, Europe) are teaming to offer advanced technology for microbial pathogen monitoring of process water and drinking water sources.... Read more

Greiner Bio-One North America, Inc. and Nano3d Biosciences Innovate to Bring New 3D Cell Culture Technology to Space Exploration

Greiner Bio-One North America, Inc. and Nano3D Biosciences, Inc. are collaborating with University of Colorado and BioServe Space Technologies to broach a new frontier in the biotechnology industry by adapting their products to perform 3D cell culture applications in a microgravity environment. In space, cell cultures spontaneously grow in three dimensions but in microgravity, routine... Read more

Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult “Ground-state” Stem Cell Technology

MINNEAPOLIS, Minnesota (March 7, 2017)- Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field intended for cloning, propagating, and differentiating adult “ground-state” stem cells from healthy and diseased epithelial tissues. Working together, Bio-Techne and MCT will transition this breakthrough technology into... Read more

Takara Bio USA Holdings, Inc. completes acquisition of WaferGen Bio-systems, Inc.

Takara Bio USA Holdings, Inc. completes acquisition of WaferGen Bio-systems, Inc. Mountain View, CA—March 1, 2017—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of WaferGen Bio-systems, Inc. (“WaferGen”), WaferGen has become a wholly-owned subsidiary of TBUSH as of February 28, 2017 (US local time). Under the merger agreement executed with... Read more

Greiner Bio-One North America, Inc. Launches New Innovative CELLdisc™ Product for Mass Cell Culture

Greiner Bio-One North America, Inc. has added a new and innovative product to the already robust portfolio for cell culture that is specifically used for mass cell culture. CELLdisc™ is a new multilayer device covering a range of cell culture surfaces from 1,000 cm2 up to 1 square meter. The innovative ergonomic design of CELLdisc™... Read more

Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products

by Sphere Fluidics | Jan 24, 2017 | News Cambridge, UK, 24th January 2017: Sphere Fluidics Limited (SF), an established Life Sciences tools company, today announced the launch of their new E-Commerce website platform to enable researchers easy access to its specialist microfluidic products. The new website functionality allows scientists rapid, global access to a patented range of specialist chemicals, microfluidic biochips... Read more

Gyros Protein Technologies appoints Gerrit van den Dool to Board of Directors

Uppsala, Sweden, 19 January 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Gerrit van den Dool to its Board of Directors, as a Non-Executive Director. With more than 25 years’ experience in the life science industry and with his... Read more